-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师总结如下:杜比公司2026财年第二季度(3月至季度)业绩表现强劲,销售额达3.96亿美元(同比增长7%),非GAAP每股收益为1.37美元,略高于市场普遍预期的3.86亿美元/1.34美元,尽管宏观经济不确定性给消费电子行业带来压力。广播业务增长最为强劲,收入达1.19亿美元(同比增长26.5%),占授权收入的32%;移动业务收入则有所放缓,为9420万美元(同比下降6%),与第一季度22%的增长率相比出现显著下降。盈利能力承压,毛利率从90.3%降至88.7%,营业利润率从29.2%降至28.5%。第三季度业绩指引令人失望,营收中值为3.1亿美元,每股收益中值为0.635美元,远低于市场预期(3.44亿美元/0.98美元)。不过,2026财年业绩指引维持在14亿至14.5亿美元营收/4.30至4.45美元,接近市场预期(14.2亿美元/4.39美元)。我们预计移动业务将受到内存短缺的挑战,但最低销量承诺能起到一定的缓冲作用。鉴于第三季度前景疲软,我们担心管理层对第四季度销量过于乐观,尤其是在内存供应仍然受限的情况下。
Related Articles
Collins Foods Confirms Partnership Arrangement Condition Met for Taco Bell Transition
Collins Foods (ASX:CKF) said conditions precedent for the transition of 20 Taco Bell restaurants to a new partnership arrangement between an affiliated company of Taco Bell and Restaurant Brands Australia have been satisfied, according to a Friday Australian bourse filing.The company said the transaction remains subject to other customary conditions, including landlord consents, a store-based employment threshold, and Australian Competition and Consumer Commission (ACCC) clearance, with completion expected between June and August, depending on regulatory approval timelines.
NZX Q1 Revenue Rises 5%
NZX (NZE:NZX) reported first-quarter revenue of NZ$32.7 million, up 5% from NZ$31.1 million in the year-ago period, according to a Friday filing on the bourse.The number of total listed securities on the exchange as of March 31 fell 1.8% year over year to 323, per the filing.
Avita Medical Appoints CEO, Chair
Avita Medical (ASX:AVH) has appointed Cary Vance as chief executive, effective immediately, according to a Friday Australian bourse filing.Vance has been acting as interim CEO since October 2025, per the filing.The company also appointed Jan Stern Reed as chair with immediate effect, the filing added.